Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment

Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer’s disease dementia in mild cognitive impairment

Abstract Background Cerebrospinal fluid (CSF) biomarkers have been used to increase the evidence of underlying Alzheimer’s disease (AD) pathology in mild cognitive impairment (MCI). However, CSF biomarker-based classification often results in conflicting profiles with controversial prognostic value....

Full description

Bibliographic Details
Main Authors: Inês Baldeiras, Isabel Santana, Maria João Leitão, Helena Gens, Rui Pascoal, Miguel Tábuas-Pereira, José Beato-Coelho, Diana Duro, Maria Rosário Almeida, Catarina Resende Oliveira
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Alzheimer’s Research & Therapy
Subjects:
Mild cognitive impairment
CSF biomarkers
Aβ42/40 ratio
Alzheimer’s disease
Online Access:http://link.springer.com/article/10.1186/s13195-018-0362-2

Internet

http://link.springer.com/article/10.1186/s13195-018-0362-2

Similar Items